Journal
AMERICAN JOURNAL OF PREVENTIVE MEDICINE
Volume 61, Issue 2, Pages 240-245Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amepre.2021.02.004
Keywords
-
Funding
- National Institute on Drug Abuse of the NIH [R01DA044207]
Ask authors/readers for more resources
The study found that the prevalence of Kratom use in the past year in the U.S. is 0.7%, with a higher likelihood of use among individuals with prescription opioid use disorder. In addition to prescription opioid use disorder, individuals who reported past-year cannabis, cocaine, and prescription stimulant misuse also had a higher likelihood of using Kratom. Further research is needed to understand the reasons for Kratom use and potential risks associated with its use alongside other drugs.
Introduction: Kratom is a plant with partial opioid agonist effects, and its use has become popular to ameliorate symptoms of opioid withdrawal. However, use has been linked to thousands of poisonings, although most have involved use of other drugs. Little is known regarding prevalence and correlates of use in the general U.S. population. Methods: Data were examined from the 2019 National Survey on Drug Use and Health, a nationally representative probability sample of non-institutionalized individuals aged >= 12 years in the U.S. (N=56,136). Prevalence and correlates of past-year kratom use were estimated. Data were analyzed in 2020. Results: An estimated 0.7% (95% CI=0.6, 0.8) of individuals in the U.S. have used kratom in the past year. Past-year proxy diagnosis of prescription opioid use disorder was associated with increased odds for kratom use (AOR=3.20, 95% CI=1.38, 7.41), with 10.4% (95% CI=6.7, 15.9) of those with use disorder reporting use. Opioid misuse not accompanied with use disorder was not associated with kratom use. Those reporting past-year cannabis use both with (AOR=4.33, 95% CI=2.61, 7.19) and without (AOR=4.57, 95% CI=3.29, 6.35) use disorder and those reporting past-year cocaine use (AOR=1.69, 95% CI=1.06, 2.69) and prescription stimulant misuse (AOR=2.10, 95% CI=1.44, 3.05) not accompanied with use disorder were at higher odds for kratom use. Conclusions: Kratom use is particularly prevalent among those with prescription opioid use disorder, but it is also prevalent among people who use other drugs. Research is needed to determine reasons for use and potential dangers associated with adding kratom to drug repertoires. (C) 2021 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available